Dear Colleagues:
The National Institutes of Health (NIH) issued the following policy notices this week. If you have any questions, please contact your Federal Contracts and Grants Officer (https://research.uci.edu/about-or/contact/staff-by-dept-assignment/) or me at warnerj@uci.edu.
- Basic Experimental Studies in Humans (BESH) Will No Longer Be Considered Clinical Trials by the NIH
(NOT-OD-26-032)
National Institutes of Health
“Effective with applications submitted to due dates on or after May 25, 2026, Basic Experimental Studies Involving Humans (BESH) will no longer be considered clinical trials by the NIH.
- Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2026
(NOT-OD-26-034)
National Institutes of Health
“Effective January 11, 2026, the salary limitation for Executive Level II is $228,000.”
Thank you,
Jeff Warner
Senior Director, Sponsored Projects
Office of Research
University of California Irvine
949-824-7654
From: Table of Contents for the NIH Guide for Grants & Contracts <NIHTOC-L@LIST.NIH.GOV> On Behalf Of Guide TOC
Sent: Friday, January 30, 2026 12:35 PM
To: NIHTOC-L@LIST.NIH.GOV
Subject: NIH Guide Notices for 01-30-2026 (The NIH Guide TOC)
NIH Guide for Grants and Contracts (Web Version)
Weekly NIH Guide Notices for January 30, 2026
Policy Notices
- NIH Removing AIDS Application Due Dates from NOFOs
(NOT-OD-26-029)
National Institutes of Health
- Basic Experimental Studies in Humans (BESH) Will No Longer Be Considered Clinical Trials by the NIH
(NOT-OD-26-032)
National Institutes of Health
- Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2026
(NOT-OD-26-034)
National Institutes of Health
General Notices
- Notice of Temporary Extension to Early-Stage Investigator (ESI) Eligibility Period
(NOT-OD-26-020)
Office of the Director, NIH
- Notice of Temporary Extension of Eligibility for the NIH Pathway to Independence Award (K99/R00)
(NOT-OD-26-021)
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of Change: Expiration of PAR-25-147 — NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
(NOT-DK-26-103)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Change: Expiration of PAR-25-089 — NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
(NOT-DK-26-104)
National Institute of Diabetes and Digestive and Kidney Diseases
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Unsubscribe from the NIH Guide Weekly TOC LISTSERV.